Replies to post #37122 on Biotech Values

[DewDiligence]

The THRM IPO went off at $7 and the stock is sitting at 6.80 as I type with more than 2M shares traded. I wonder how many people realize that THRM’s anti-wrinkle procedure is little more than a time consuming, expensive, and painful placebo.